Streetbeat News

Equity Actions

BEAM

Beam Therapeutics (NASDAQ:BEAM) received mixed analyst ratings with an updated average 12-month price target of $46.2, reflecting a 52.32% increase from the previous target. Analysts from Wedbush, BMO Capital, Barclays, RBC Capital, and JP Morgan provided insights, with some maintaining their ratings and others raising their price targets. The company's financial health appears strong, with significant revenue growth, high net margin, and solid ROE and ROA, indicating a robust market position and operational efficiency.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 6:00 pm

LIXT

Lixte Biotechnology Holdings has filed for a $50M offering according to an SEC filing. This move could potentially impact the company's financial flexibility and future growth prospects.

Portfolio Pulse from Benzinga Newsdesk

April 23, 2024 | 5:50 pm

SNDL

SNDL (NYSE:SNDL) reported a decrease in short interest, with 10.40 million shares sold short, representing 3.95% of its float. This marks a 6.62% decline from its last report. The current short interest suggests a bullish sentiment among investors, as it is lower than the peer group average of 11.46%. Short interest is a key indicator of market sentiment, and a decrease often signals that investors are becoming more optimistic about the stock's future performance.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 5:45 pm

DIS

DJT

GOOG

META

NFLX

PARA

TMUS

TTD

Today's whale activity in the Communication Services sector highlighted significant options trading across various companies, indicating potential trading opportunities. Notable trades included bearish and bullish sentiments on stocks like PARA, DJT, SE, TMUS, GOOG, META, NFLX, VZ, TTD, and DIS, with varying expiration dates and strike prices. This activity could signal market movements based on the large sums of money involved and the strategic positions taken by these entities.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 5:35 pm

AMD

APH

AVGO

CDNS

CLSK

IREN

MSFT

NVDA

SMCI

SOUN

Today's whale activity in the Information Technology sector highlighted significant options trading across various companies, indicating bullish, bearish, and neutral sentiments. Notable trades were observed in NVDA, APH, AMD, CLSK, MSFT, SMCI, IREN, AVGO, CDNS, and SOUN, with varying expiration dates, strike prices, and sentiments. This activity could signal upcoming movements in these stocks based on the large sums of money involved and the strategic positions taken by 'whales' in the market.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 5:35 pm

SMFL

Smart for Life (NYSE:SMFL) has seen a significant increase in short interest, with the short percent of float rising 260.64% to 35.09%. This indicates a bearish market sentiment towards SMFL, as more traders are betting against the stock. However, an increase in short interest can sometimes be bullish, suggesting a potential for a short squeeze. SMFL's short interest is notably higher than its peer group average of 2.68%.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 5:15 pm

DOCS

Six analysts have recently updated their ratings on Doximity (NYSE:DOCS), showing a mix of indifference and slight bearishness, with four maintaining an indifferent stance and two somewhat bearish. The average 12-month price target for DOCS has been raised to $28.00, indicating a 12.0% increase from the previous target of $25.00. The company's financials reveal strong performance, with significant revenue growth, high net margin, and excellent ROE and ROA, suggesting a robust financial health and operational efficiency.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 5:01 pm

ALHC

Four analysts have recently updated their ratings on Alignment Healthcare (NASDAQ:ALHC), showing a mix of bullish and bearish sentiments. The average 12-month price target is now $7.00, down 34.4% from previous estimates, with individual targets ranging from $4.50 to $9.00. Analysts from Stifel, Piper Sandler, Barclays, and UBS have adjusted their price targets and ratings due to changes in market conditions and company performance. Alignment Healthcare, a provider of Medicare Advantage plans, has shown impressive revenue growth of 28.63% as of December 31, 2023, but faces challenges in profitability and debt management.

Portfolio Pulse from Benzinga Insights

April 23, 2024 | 5:00 pm

VAXX

Vaxxinity Inc (NASDAQ:VAXX) shares dropped 10% to $0.24 due to volatility following the announcement of its voluntary delisting and deregistration from Nasdaq. The decision was made to address non-compliance with the minimum bid price requirement and to focus on R&D without the distraction of stock price fluctuations. Delisting is scheduled for around May 9, with plans to move to over-the-counter trading.

Portfolio Pulse from Henry Khederian

April 23, 2024 | 4:12 pm

SPCE

Virgin Galactic Holdings Inc (NYSE:SPCE) shares surged 19% to $0.89, rebounding from recent lows after announcing a potential reverse stock split, with a ratio between 1-for-2 and 1-for-20. The decision will be voted on at the annual meeting on June 12. The stock has declined about 35% over the past month, hitting all-time lows. Approximately 25% of SPCE shares are being sold short, indicating a potential for a short squeeze. Over the past year, SPCE shares have fallen 73.66%, with a significant drop of 38.34% in the last month alone.

Portfolio Pulse from Henry Khederian

April 23, 2024 | 4:12 pm